Goldfield Announces Executive Promotions in its Electrical Construction Operations
Jan 03, 2017 22:11 pm UTC| Business
MELBOURNE, Fla., Jan. 03, 2017 -- The Goldfield Corporation (NYSE MKT:GV) (“Goldfield” or the “Company”) announced today the appointment of Greg Crutchfield as President of Power Corporation of America (“PCA”) and...
Fastenal Company Announces Conference Call to Review 2016 Annual and Fourth Quarter Earnings
Jan 03, 2017 22:05 pm UTC| Business
WINONA, Minn., Jan. 03, 2017 -- Fastenal Company (Nasdaq:FAST) announced the date and time for their conference call to review 2016 annual and fourth quarter results, as well as current operations. The conference call...
Extraction Oil & Gas Announces Participation at Goldman Sachs Global Energy Conference
Jan 03, 2017 22:03 pm UTC| Business
DENVER, Jan. 03, 2017 -- Extraction Oil Gas, Inc. (NASDAQ:XOG), an oil and gas exploration and production company with assets primarily in the Wattenberg Field in the Denver-Julesburg Basin of Colorado, today announced...
SP Plus Corporation Announces Participation in the 2017 ICR Conference
Jan 03, 2017 22:00 pm UTC| Business
CHICAGO, Jan. 03, 2017 -- SP Plus Corporation (Nasdaq:SP), a leading national provider of parking, ground transportation and related products and services to commercial, institutional and municipal clients throughout...
Jan 03, 2017 21:55 pm UTC| Business
DALLAS, Texas, Jan. 03, 2017 -- Southcross Energy Partners, L.P. (NYSE:SXE) (“Southcross”) announced today that it has secured an amendment to its revolving credit agreement. The amendment provides for a full two-year...
CytoDyn Announces Investment Community Conference Call for January 5, 2017
Jan 03, 2017 21:53 pm UTC| Business
VANCOUVER, Washington, Jan. 03, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that...
Jan 03, 2017 21:53 pm UTC| Business
EMERYVILLE, Calif., Jan. 03, 2017 -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced the completion of a Phase 1 clinical trial of ADS-4101, an investigational drug in development for the treatment of partial...